The brief

Economy

FTC and seven states seek contempt ruling against Shkreli over pharma ban

Martin Shkreli's 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and they are asking a judge to hold him in contempt.

Too new to price

Markets open once the world starts taking sides. When they do, the odds and a way to back your read land right here.

Odds and movement update live. Fills are simulated until you connect a wallet.

Read the full story

from The Guardian

​FTC and seven states seek contempt ruling against Shkreli over pharma ban

FTC and seven states seek contempt ruling against Shkreli over pharma ban